Optical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Régional Metz-Thionville

About this trial

Skin carcinomas are the most commonly diagnosed cancers in fair-skinned populations, for example in France, Western Europe, and North America in particular. The OpticSkin project will build and make available to the general public and the scientific and medical community a histological and optical spectroscopic database of healthy, precancerous, and cancerous human skin in terms of absorption, elastic and inelastic scattering (Raman), steady-state and time-resolved autofluorescence, and polarization. The aim is to identify spectroscopic signatures that will be useful for diagnosis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients with skin carcinomas and actinic keratoses

Disqualifiers

minor patient

Trial population

The OpticSkin study will be conducted on paraffin blocks containing skin samples taken from the 140 patients included in the SpectroLive study NCT0295626, ID-RCB: 2016-A00608-43.

Trial design

Design model

Case-only

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

automated recognition

automated recognition (by supervised classification) of optical data acquired on different histological classes

Time frame
Until the end of the study on average 2 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.